AMSTERDAM, Dec. 19, 2019 /PRNewswire/ -- The Association of Universities in the Netherlands (VSNU), The Netherlands Federation of University Medical Centres (NFU), The Dutch Research Council (NWO), and the global information and analytics business Elsevier, have reached a framework agreement. NWO President Stan Gielen said, "This agreement is in accordance with Plan S and is a huge step towards 100 percent open access and therefore a major breakthrough for open science in the Netherlands."
"Overall it means that Dutch research institutions and Elsevier will embark on a new and innovative approach to scientific research, making it more transparent, collaborative, efficient, and in support of social issues and questions."
VSNU's chief negotiator, Tim van der Hagen added, "This is the beginning of a new way of working for science. We will be in the driving seat of what's important for science in the future and the applicable rules of engagement and services needed in this context."
The framework agreement, with a transition period from January 1 through May 1, 2020, provides Dutch researchers with full reading access to all Elsevier journals, and allows (unlimited) open access publishing in Elsevier journals. In addition, a range of pilots will be undertaken to develop tools and services in support of (open) science and research intelligence.
VSNU, NFU, NWO and Elsevier acknowledge that especially the development of these new services has been a cause for some concerns in the community. To address this, an initial set of clear principles have been agreed to by the partner organisations. These are:
- Interoperable: no vendor lock in. Researchers and institutions can also use their own tools.
- Future proof: system should be flexible to different setups and different agreements.
- Vendor/publisher neutral: system development is not limited to any specific vendor.
- Researchers and/or institutions own their own research data (not Elsevier).
In the coming months, a working group will further define the rules of engagement and the governance structure will be worked out. To bridge the transition period, the parties have agreed on a Memorandum of Understanding to provide continued and expanded access to the reading and publishing services of the agreement. If the parties reach a final agreement, the contract will be made publicly available and registered on the ESAC-registry.
"This MoU marks an important step towards achieving Dutch research and open science ambitions, and further solidifying the Netherlands' standing as an innovative leader in the international research community. This announcement has been a long time in the making, meaning four partners in research have taken time and allowed one another to explore the opportunities and perimeters of this new and unique collaboration. We look forward to formalizing the agreement with our trusted partners in the early months of 2020," said Gino Ussi, Executive Vice President at Elsevier.
More information can be found in the digital Q&A here.
About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
Media contact
Sacha Boucherie, Global Communications
Elsevier
[email protected]
SOURCE Elsevier
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO72961&Transmission_Id=201912190820PR_NEWS_USPR_____IO72961&DateId=20191219)
Share this article